Release Date: November 13, 2020 This content is archived. BUFFALO, N.Y. – Dhaval K. Shah, PhD, associate professor in the University at Buffalo School of Pharmacy and Pharmaceutical Sciences, will ...

Dhaval Shah can speak to the media about targeted drug therapies and biologics, including monoclonal antibodies, for cancer and other diseases. A former principal scientist at Pfizer Inc., Shah’s work ...

Dhaval K. Shah, associate professor in the School of Pharmacy and Pharmaceutical Sciences, has been named the recipient of the 2020 North American New Investigator Award from the International Society ...

The award is presented to an ISSX member who has made significant contributions to their field of study. "Dr. Shah's cutting‐edge research in protein therapeutics and mechanistic modeling extensively ...